Bosutinib
Bosutinib is a Bcr-Abl kinase inhibitor for the treatment of Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) .
Product Specifications
CAS Number
380843-75-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
530.45
Molecular Formula
C26H29Cl2N5O3
Notes
Research use only, not for human use.
Receptor
Abl| MAPK| c-Src
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog